Quick Takeaways
- This page summarizes Melissa B. Epperly's Form 4 filing for Roivant Sciences Ltd. (ROIV).
- 1 reported transaction and 0 derivative rows are listed below.
- Filing timestamp: 23 Jan 2024, 21:00.
Melissa B. Epperly - 19 Jan 2024 Form 4 Insider Report for Roivant Sciences Ltd. (ROIV)
- Role
- Director
- Signature
- By: /s/ Jo Chen, as Attorney-in-Fact for Melissa Epperly
- Issuer symbol
- ROIV
- Transactions as of
- 19 Jan 2024
- Net transactions value
- $0
- Form type
- 4
- Filing time
- 23 Jan 2024, 21:00:30 UTC
- Previous filing
- 18 Oct 2023
- Next filing
- 05 Feb 2024
- SEC
- View on sec.gov
Quoteable Key Fact
"Melissa B. Epperly filed Form 4 for Roivant Sciences Ltd. (ROIV) on 23 Jan 2024."
What Changed
- Previous filing in this sequence was filed on 18 Oct 2023.
- Current net transaction value: $0.
Why This Matters
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Official SEC Source
Transactions Table
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ROIV | Common Shares | Award | $0 | +1,207 | +5.9% | $0.000000 | 21,538 | 19 Jan 2024 | Direct | F1 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
| Id | Content |
|---|---|
| F1 | Reflects an award of Common Shares received pursuant to the Company's Non-Employee Director Compensation Plan that was fully vested as of the grant date. |